These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 3528990)

  • 41. Brugia pahangi: circulating antibodies to adult worm antigens in uninfected progeny of homologously infected female jirds.
    Bosshardt SC; McVay CS; Coleman SU; Klei TR
    Exp Parasitol; 1991 May; 72(4):440-9. PubMed ID: 2026218
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Phosphorylcholine-bearing antigens in filarial nematode parasites: analysis of somatic extracts, in-vitro secretions and infection sera from Brugia malayi and B. pahangi.
    Maizels RM; Burke J; Denham DA
    Parasite Immunol; 1987 Jan; 9(1):49-66. PubMed ID: 2436131
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Detection of antibodies in Brugia pahangi-infected cats by counter immunoelectrophoresis, indirect fluorescent antibody test and enzyme-linked immunosorbent assay.
    Au AC; Denham DA; Draper CC
    Z Parasitenkd; 1982; 68(3):313-20. PubMed ID: 6760573
    [TBL] [Abstract][Full Text] [Related]  

  • 44. IgG subclass recognition of Loa loa antigens and their correlation with clinical status in individuals from Gabon.
    Akue JP; Hommel M; Devaney E
    Parasite Immunol; 1998 Aug; 20(8):387-93. PubMed ID: 9767604
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Brugia pahangi: granulomatous lesion development in jirds following single and multiple infections.
    Klei TR; Enright FM; McDonough KC; Coleman SU
    Exp Parasitol; 1988 Jun; 66(1):132-9. PubMed ID: 3366211
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Inhibition of antigen-driven proliferative responses and enhancement of antibody production during infection with Brugia pahangi.
    Miller S; Schreuer D; Hammerberg B
    J Immunol; 1991 Aug; 147(3):1007-13. PubMed ID: 1861067
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Heat shock cognate 70 is a prominent immunogen in Brugian filariasis.
    Selkirk ME; Denham DA; Partono F; Maizels RM
    J Immunol; 1989 Jul; 143(1):299-308. PubMed ID: 2659668
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Induction of lymphatic lesions by Brugia pahangi in jirds with large and small preexisting homologous intraperitoneal infections.
    Klei TR; McDonough KC; Coleman SU; Enright FM
    J Parasitol; 1987 Apr; 73(2):290-4. PubMed ID: 3585623
    [TBL] [Abstract][Full Text] [Related]  

  • 49. IgE responses in human filariasis. IV. Parallel antigen recognition by IgE and IgG4 subclass antibodies.
    Hussain R; Ottesen EA
    J Immunol; 1986 Mar; 136(5):1859-63. PubMed ID: 3950405
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Determination of circulating filarial antigen using monoclonal antibody against Brugia malayi adult worm ES antigen with Dot-ELISA].
    Zheng HJ
    Zhonghua Yu Fang Yi Xue Za Zhi; 1990 Jan; 24(1):25-7. PubMed ID: 2340764
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Detection of serum antibodies in bancroftian filariasis patients with antigens from different developmental stages of Brugia malayi].
    Shi FT; Luo XF
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 1987; 5(3):188-90. PubMed ID: 3329069
    [No Abstract]   [Full Text] [Related]  

  • 52. Human in vitro immune reactions to animal filariids.
    Sim BK; Kwa BH; Mak JW
    Trop Med Parasitol; 1987 Mar; 38(1):11-4. PubMed ID: 3602834
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Surface antigens of a filarial nematode: analysis of adult Brugia pahangi surface components and their use in monoclonal antibody production.
    Sutanto I; Maizels RM; Denham DA
    Mol Biochem Parasitol; 1985 May; 15(2):203-14. PubMed ID: 4010706
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Bancroftian filariasis in Haiti: preliminary characterization of the immunological responsiveness of microfilaremic individuals.
    Lammie PJ; Leiva LE; Ruff AJ; Eberhard ML; Lowrie RC; Katz SP
    Am J Trop Med Hyg; 1988 Jan; 38(1):125-9. PubMed ID: 3277457
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Protective immunity against Brugia malayi infective larvae in mice. II. Induction by a T cell-dependent antigen isolated by monoclonal antibody affinity chromatography and SDS-PAGE.
    Hammerberg B; Nogami S; Nakagaki K; Hayashi Y; Tanaka H
    J Immunol; 1989 Dec; 143(12):4201-7. PubMed ID: 2480388
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The analysis of the humoral response of the BALB/c mouse immunized with radiation attenuated third stage larvae of Brugia pahangi.
    Bancroft A; Devaney E
    Parasite Immunol; 1993 Mar; 15(3):153-62. PubMed ID: 8316409
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The effect of sera from cats infected with Brugia pahangi and subsequently treated with levamisole on the infectivity of third-stage larvae of B. pahangi.
    Denham DA; Samad R
    J Parasitol; 1988 Feb; 74(1):190-1. PubMed ID: 3357102
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Evaluation of specific humoral immune responses in human filariasis.
    Kumar H; Malhotra A; Santhanam S; Jain DC; Ghosh TK
    Folia Parasitol (Praha); 1987; 34(3):249-54. PubMed ID: 3311932
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Detection of antibodies in cats infected with filarial parasites by the indirect immunofluorescence technique.
    Prasomsitti P; Mak JW; Sucharit P; Liew LM
    Southeast Asian J Trop Med Public Health; 1983 Sep; 14(3):353-6. PubMed ID: 6362016
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Modulation of lymphocyte activation by soluble Brugia pahangi extracts.
    Leiva LE; Lammie PJ
    Trop Med Parasitol; 1989 Sep; 40(3):327-31. PubMed ID: 2617042
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.